drugset
drugset / Trial / NCT05564832

Pharmacological Treatment of Presbyopia

NCT05564832 ↗

Phase 0 Unknown 75 enrolled Shahid Beheshti University of Medical Sciences
Non-randomizedParallel-groupSingle-blindTreatment

Summary

In this clinical trial, a total of 75 presbyopic patients in the age range of 40 to 60 years old will be participated. The right eyes of 45 patients will be treated by Biocarpine® and they will be considered as the case group, their left eyes will be defined as the controls. In another case group, the right eyes of 30 patients will received Vuity® eye drops and their left eyes will be considered as controls.

Timeline

Start
2022-08-01
Primary completion
2022-12-01
Completion
2023-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Pilocarpine Unknown 1.25 % Topical

Indications

No indication recorded.